Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportData Analysis & Management

Classification of Amyloid status in cognitively normal subjects using NeuroRadiomics

Sandeep Golla, Jarith Ebenau, Sander Verfaillie, Maqsood Yaqub, Tessa Timmers, Bart van Berckel, Wiesje van der Flier and Ronald Boellaard
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 3177;
Sandeep Golla
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarith Ebenau
2Alzheimer Center and department of Neurology, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sander Verfaillie
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maqsood Yaqub
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tessa Timmers
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart van Berckel
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wiesje van der Flier
1Amsterdam UMC, location VUmc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Boellaard
3Vumc, Dept. Nuclear Medicine & PET Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3177

Introduction: Classification of the amyloid status of [18F]Florbetapir positron emission tomography scans is normally performed by visual assessment. In the earliest, preclinical stages of Alzheimer’s disease, visual reading can be particularly challenging due to relatively lower amyloid load levels in the brain. Moreover, visual interpretation requires a highly experienced Nuclear Medicine physician to perform these classifications. Therefore, the aim of this study was to identify the optimal Radiomics features for classification of amyloid status in a sample of cognitively normal individuals with Subjective Cognitive Decline (SCD).

Methods: SUVr images of [18F]Florbetapir PET scans of 155 SCD subjects from SCIENCe cohort were included. 118 were classified as Aβ- and 37 as Aβ+ by visual assessment. T1 weighted MRI scans were also acquired from the subjects. Grey and white matter segmentations from the T1 weighted MRI scans were obtained using SPM8. Radiomics features were extracted using the RaCat software1. Three bin configurations were tested: bin size 0.05 and 0.25, and a fixed bin number of 64. Three regions (whole brain, grey and white matter) were studied. Feature elimination to remove redundant and less statistically relevant features was performed in three steps: (1) features with less significant differences, (2) features highly correlated with SUVr or volume, (3) pair-wise elimination (using mutual correlations). Features common for all nine combinations or the regions (post elimination) were considered optimal. A simple T-Test was performed to assess statistically significant differences between the Aβ+ and Aβ- subjects for each radiomics feature and region in step one of the feature elimination. Spearman’s rank correlations was used in the second step of feature elimination. In this step, a threshold of 0.7 (correlation) was used. Any feature with a correlation higher than this threshold to either SUVr or volume was removed.

Results: A total of 478 radiomics features per combination were extracted. Less than 22 radiomics features per combination survived all three steps of feature elimination (Figure 1a). PET uptake metrics Original mean and Exact Volume were the only features common among all the nine combinations post feature elimination. Optimal features per region of interest are illustrated in Figure 1b. Most of these features that are either common at a region of interest level or for all the nine combinations had significant difference between the Aβ- and Aβ+ scans but no significant differences among bin configurations were observed.

Conclusions: A significant difference between the amyloid positive and negative scans could be obtained using most of the features after redundancy feature elimination. However, none of the metrics were able to fully differentiate subjects. Yet, some features were better able to differentiate subject groups better than the commonly used SUVr. The latter suggests opportunities for radiomics to improve classification of amyloid status.

References

Pfaehler E, Zwanenburg A, de Jong JR, Boellaard R. “RaCaT: An open source and easy to use radiomics calculator tool”. PLoS One. 2019 Feb 20;14(2)

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Classification of Amyloid status in cognitively normal subjects using NeuroRadiomics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Classification of Amyloid status in cognitively normal subjects using NeuroRadiomics
Sandeep Golla, Jarith Ebenau, Sander Verfaillie, Maqsood Yaqub, Tessa Timmers, Bart van Berckel, Wiesje van der Flier, Ronald Boellaard
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3177;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Classification of Amyloid status in cognitively normal subjects using NeuroRadiomics
Sandeep Golla, Jarith Ebenau, Sander Verfaillie, Maqsood Yaqub, Tessa Timmers, Bart van Berckel, Wiesje van der Flier, Ronald Boellaard
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3177;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An international study of inter-site variability in pre-treatment 99mTc MAA dosimetry for Yttrium-90 radioembolization: analyses from the TARGET phantom study
  • Feasibility of standard and generalized Patlak Models for dynamic imaging of multiple organs using the uEXPLORER PET scanner
  • A Matlab-based Kinetic Modeling tool for fast and robust estimation of Patlak-based parameters with uncertainty information
Show more Data Analysis & Management

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire